Genentech, Inc. v. Sandoz Inc.
Opinion
Case: 22-1595 Document: 24 Page: 1 Filed: 06/16/2022
NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit
______________________
GENENTECH, INC., INTERMUNE, INC.,
Plaintiffs-Appellants v.
SANDOZ INC., LEK PHARMACEUTICALS, D.D.,
Defendants-Appellees ______________________
2022-1595 ______________________
Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-00078-RGA, Judge Richard G. Andrews.
------------------------------------------------- GENENTECH, INC., INTERMUNE, INC.,
Plaintiffs-Appellees v.
SANDOZ INC., LEK PHARMACEUTICALS, D.D.,
Defendants-Appellants ______________________
2022-1714 ______________________
Case: 22-1595 Document: 24 Page: 2 Filed: 06/16/2022 2 GENENTECH, INC. v. SANDOZ INC.
Appeal from the United States District Court for the District of Delaware in No. 1:19-cv-00078-RGA, Judge Richard G. Andrews.
______________________ ON MOTION ______________________ ORDER
Upon consideration of the parties’ joint motion to vol- untarily dismiss Appeal No. 2022-1714,
IT IS ORDERED THAT: (1) The motion is granted. Appeal No. 2022-1714 is dismissed. The revised official caption for the remaining appeal, Appeal No. 2022-1595, is reflected above.
(2) Each side shall bear its own costs in Appeal No. 2022-1714.
(3) The Clerk of Court shall transmit a copy of this or- der to the merits panel assigned to Appeal No. 2022-1595.
(4) Genentech, Inc. and InterMune, Inc.’s reply brief in Appeal No. 2022-1595 is due no later than July 5, 2022.
FOR THE COURT June 16, 2022 /s/ Peter R. Marksteiner
Date Peter R. Marksteiner
Clerk of Court ISSUED AS A MANDATE (as to 2022-1714 only):
June 16, 2022
Case-law data current through September 30, 2026. Source: CourtListener bulk data.